GR920300106T1 - Antihypercholesterolemics. - Google Patents

Antihypercholesterolemics.

Info

Publication number
GR920300106T1
GR920300106T1 GR920300106T GR920300106T GR920300106T1 GR 920300106 T1 GR920300106 T1 GR 920300106T1 GR 920300106 T GR920300106 T GR 920300106T GR 920300106 T GR920300106 T GR 920300106T GR 920300106 T1 GR920300106 T1 GR 920300106T1
Authority
GR
Greece
Prior art keywords
antihypercholesterolemics
image
compounds
useful
structural formula
Prior art date
Application number
GR920300106T
Other languages
English (en)
Inventor
James D Bergstrom
Jerrold M Liesch
Otto D Hensens
Janet C Onishi
Leeyuan Huang
Frank L Vanmiddlesworth
Maria T Diez
Kenneth F Bartizal
Mary Nallin
Walter Rozdilsky
Fernando Pelaez Perez
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/496,742 external-priority patent/US5096923A/en
Priority claimed from US07/626,071 external-priority patent/US5053425A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of GR920300106T1 publication Critical patent/GR920300106T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
GR920300106T 1990-03-21 1993-02-17 Antihypercholesterolemics. GR920300106T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49673190A 1990-03-21 1990-03-21
US49674990A 1990-03-21 1990-03-21
US07/496,742 US5096923A (en) 1990-03-21 1990-03-21 Novel squalene synthetase inhibitors
US07/626,071 US5053425A (en) 1990-03-21 1990-12-11 Novel anti-fungal compounds

Publications (1)

Publication Number Publication Date
GR920300106T1 true GR920300106T1 (en) 1993-02-17

Family

ID=27504381

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920300106T GR920300106T1 (en) 1990-03-21 1993-02-17 Antihypercholesterolemics.

Country Status (17)

Country Link
EP (1) EP0450812B1 (el)
JP (1) JPH04279589A (el)
KR (1) KR910016931A (el)
AT (1) ATE104982T1 (el)
AU (1) AU640755B2 (el)
CA (1) CA2038517A1 (el)
CS (1) CS71991A2 (el)
DE (2) DE450812T1 (el)
DK (1) DK0450812T3 (el)
ES (1) ES2052463T1 (el)
GR (1) GR920300106T1 (el)
HU (1) HUT61555A (el)
IE (1) IE910924A1 (el)
IL (1) IL97535A0 (el)
NO (1) NO911121L (el)
NZ (1) NZ237448A (el)
PT (1) PT97077A (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97251A0 (en) * 1990-03-21 1992-05-25 Merck & Co Inc Antihypercholesterolemic 2,8-dioxabicyclo(3,2,1)octane derivatives,their preparation and pharmaceutical compositions containing them
GB9100437D0 (en) * 1991-01-09 1991-02-20 Glaxo Group Ltd Chemical compounds
GB9105152D0 (en) * 1991-03-12 1991-04-24 Glaxo Group Ltd Chemical compounds
US5256689A (en) * 1991-05-10 1993-10-26 Merck & Co., Inc. Cholesterol lowering compounds
CA2109523A1 (en) * 1991-05-10 1992-11-26 Robert M. Burk Novel cholesterol lowering compounds
US5506262A (en) * 1991-05-10 1996-04-09 Merck & Co., Inc. Cholesterol lowering compounds
US5200342A (en) * 1991-06-14 1993-04-06 Merck & Co., Inc. Squalene synthetase inhibitors and processes therefrom
US5250424A (en) * 1991-06-14 1993-10-05 Merck & Co., Inc. Processes for preparing novel squalene synthetase inhibitors
CA2071723A1 (en) * 1991-06-27 1992-12-28 Gerald F. Bills Culture of exserohilum rostratum and processes therefrom
EP0524677A1 (en) * 1991-07-16 1993-01-27 Glaxo Group Limited Cyclic ketal derivatives
EP0598021A1 (en) * 1991-08-07 1994-05-25 Merck & Co. Inc. Novel cholesterol lowering compound
GB9121380D0 (en) * 1991-10-08 1991-11-20 Glaxo Group Ltd Chemical compounds
GB2261374A (en) * 1991-11-15 1993-05-19 Merck & Co Inc Inhibitors of farnesyl protein transferase as anti-cancer agents
US5252471A (en) * 1992-03-09 1993-10-12 Merck & Co., Inc. Directed biosynthesis of cholesterol lowering compounds
WO1993017557A1 (en) * 1992-03-09 1993-09-16 Merck & Co., Inc. Cholesterol lowering compounds produced by directed biosynthesis
US5294627A (en) * 1992-08-27 1994-03-15 Merck & Co., Inc. Directed biosynthesis of biologically active compounds
GB9205136D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
GB9205140D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
EP0568946A1 (en) * 1992-05-08 1993-11-10 Takeda Chemical Industries, Ltd. Compound TAN-1607A, its derivatives, their production, and use thereof
US5260215A (en) * 1992-07-20 1993-11-09 Merck & Co., Inc. Fungal microorganism ATCC 74167 capable of producing cholesterol lowering compounds
US5283256A (en) * 1992-07-22 1994-02-01 Merck & Co., Inc. Cholesterol-lowering agents
US5322855A (en) * 1992-10-19 1994-06-21 Merck & Co., Inc. Cholesterol lowering compounds
US5447717A (en) * 1993-02-25 1995-09-05 Merck & Co., Inc. Cholesterol-lowering agents
US5430055A (en) * 1994-04-08 1995-07-04 Pfizer Inc. Inhibitor of squalene synthase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276216A (en) * 1980-07-31 1981-06-30 Ortho Pharmaceutical Corporation Synthesis of dioxabicyclo[3.2.1]octanes and oxepanes
IL97251A0 (en) * 1990-03-21 1992-05-25 Merck & Co Inc Antihypercholesterolemic 2,8-dioxabicyclo(3,2,1)octane derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69101802T2 (de) 1994-10-27
HUT61555A (en) 1993-01-28
NO911121L (no) 1991-09-23
DE69101802D1 (de) 1994-06-01
IE910924A1 (en) 1991-09-25
AU7368391A (en) 1993-01-28
NZ237448A (en) 1993-11-25
HU910930D0 (en) 1991-10-28
PT97077A (pt) 1991-11-29
NO911121D0 (no) 1991-03-20
AU640755B2 (en) 1993-09-02
KR910016931A (ko) 1991-11-05
CS71991A2 (en) 1991-11-12
EP0450812A1 (en) 1991-10-09
IL97535A0 (en) 1992-06-21
ATE104982T1 (de) 1994-05-15
CA2038517A1 (en) 1991-09-22
DE450812T1 (de) 1992-11-26
ES2052463T1 (es) 1994-07-16
DK0450812T3 (da) 1994-06-06
JPH04279589A (ja) 1992-10-05
EP0450812B1 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
GR920300106T1 (en) Antihypercholesterolemics.
GB9002922D0 (en) 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation
AU658781B2 (en) Substituted azoles and processes for the preparation thereof
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
ES8104275A1 (es) Un metodo para la preparacion de derivados de ftalimidina
ZA939476B (en) Inhibitors of hiv protease useful for the treatment of aids
HU9403690D0 (en) Branched-amino-substituted thiazoles, process for their preparation and the pharmaceutical compositions which contan them
EP0924199A4 (el)
EP0587188A3 (en) Aryl and heterocyclic substituted propenamide derivatives
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
GR3006946T3 (el)
DK0644188T3 (da) Fremgangsmåde til fremstilling af svovlforbindelser afledt af imidazol og de derved opnåede mellemprodukter
AU2021988A (en) Novel compounds and processes for synthesis thereof
HU913370D0 (en) Process for the production of 8-azabicyclo(3.2.1)octilalkyl-tiazolydinones, the compounds, and medical preparations containing them
MY111872A (en) Herbicidal substituted bicyclic triazoles
TW262462B (el)
SE8001620L (sv) Merkaptoacylderivat av ketosubstituerad prolin- och pipekolinsyra
HU9400737D0 (en) Process for preparation of 2-substituted-5-chlorimidazole-4-carbaldehydes
IL110646A0 (en) Process for the preparation of azoxycyanide compounds
IT1255094B (it) Derivati tetraidropiridoimidazolonici come agenti nootropici
UA19979A (uk) Полівіhіл-траhс-3-(4-фторфеhіл)акрилат як фоточутливий орієhтуючий матеріал для рідких кристалів